NK
Nalini Kanta Panda
About Nalini Kanta Panda
Data last updated:
Nalini Kanta Panda is a Director at Posian Pharma Private Limited (since 2025). The company operates in Chemicals. Posian Pharma Private Limited reported revenue of ₹30.3 Lakh (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Posian Pharma Private Limited U24232OR2010PTC011689 | Director | 27 Sep 2025 | ₹30.3 Lakh (FY 2023) | Active |
Board colleagues of Nalini Kanta Panda
| Name | DIN | Company | Designation |
|---|---|---|---|
| Samir Kumar Paikaray | 07081392 | Posian Pharma Private Limited | Director |
| Shubhrajyoti Panda | 11319241 | Posian Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nalini Kanta Panda
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nalini Kanta Panda
Nalini Kanta Panda currently holds 1 directorship: Posian Pharma Private Limited (Director, since 27 Sep 2025, revenue ₹30.3 Lakh (FY 2023)).
Nalini Kanta Panda was first appointed on 27 Sep 2025 as Director at Posian Pharma Private Limited.
The current boards of Nalini Kanta Panda's companies include Samir Kumar Paikaray (Posian Pharma Private Limited), Shubhrajyoti Panda (Posian Pharma Private Limited).